Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatric Neurology

How Is a FNAIT Intracranial Hemorrhage Monitored?

At a Glance

Long-term monitoring after a FNAIT-related intracranial hemorrhage involves a care team of pediatric neurologists and developmental specialists. Seeking prompt early intervention and tracking physical and cognitive milestones are crucial to optimizing your baby's long-term developmental outcomes.

If your newborn experienced an intracranial hemorrhage (ICH) due to fetal and neonatal alloimmune thrombocytopenia (FNAIT), long-term monitoring will involve a structured neurodevelopmental follow-up plan. Leaving the NICU is a major milestone, and while the road ahead requires vigilance, remember to take time to bond with and enjoy your new baby. To support their growth, your child will need a multidisciplinary care team—including a pediatric neurologist and developmental specialists—to track their physical, cognitive, and behavioral milestones [1]. Because outcomes can vary depending on the severity of the bleed, an evaluation by early intervention professionals should be requested promptly to give your child the best possible start [2].

Building Your Care Team

Once you are discharged, your child’s care should transition to specialists who can monitor their brain development over time.

  • Pediatric Neurologist: This specialist will monitor your child for structural changes in the brain or any risk of seizures. They may recommend follow-up imaging (like an MRI or cranial ultrasound) in the first few months to check for post-hemorrhagic ventricular dilatation (PHVD)—a condition where cerebrospinal fluid builds up in the brain’s ventricles [3][4].
  • Developmental Pediatrician: They will perform standardized assessments to evaluate cognitive, language, and motor skills. For example, they will commonly use the Bayley Scales of Infant and Toddler Development at around 18 to 24 months of age [5][6].
  • Early Intervention (EI) Professionals: Physical therapists (PT), occupational therapists (OT), and speech-language pathologists will work with your child to encourage milestone progression and address any delays early.

What to Watch For as Your Child Grows

Monitoring your child involves a combination of at-home observation and routine medical check-ups.

  • Physical Milestones: Pay attention to motor skills such as rolling over, sitting up unassisted, crawling, and walking. Delays in these areas, or abnormal muscle stiffness, can be early signs of motor challenges like cerebral palsy, which are more closely monitored in children who had severe bleeds [7][8].
  • Speech and Cognitive Development: Monitor how your child communicates, responds to their name, and learns new words. Some cognitive or learning difficulties may not become fully apparent until your child reaches preschool or school age [9][10].
  • Behavioral and Social Signs: Some research suggests a potential association between FNAIT and social or developmental differences, including autism spectrum disorder [7]. Because of this, it is important to attend all well-child visits where your pediatrician will conduct standard autism screenings (typically at 18 and 24 months) and discuss any behavioral concerns you might have.
  • Signs of Fluid Buildup: In the months following an ICH, your pediatrician should regularly measure your baby’s head circumference. Rapid head growth can indicate progressive PHVD, which might require surgical intervention to relieve pressure [11][12].

How the Severity of the Hemorrhage Affects Outcomes

The long-term outlook for a child with an ICH depends heavily on the grade (severity, typically graded I through IV) of the hemorrhage.

  • Lower-Grade Bleeds (Grades I and II): These involve smaller amounts of bleeding. Many children with lower-grade hemorrhages go on to have completely normal development, though they remain at a slightly increased risk for mild learning or behavioral challenges [13][9]. Consistent, long-term follow-up remains important because some learning challenges may only emerge later in childhood.
  • Higher-Grade Bleeds (Grades III and IV): These are more severe and involve bleeding that expands the brain’s ventricles or enters the brain tissue itself. These carry a higher risk of adverse long-term neurodevelopmental outcomes, such as cerebral palsy, intellectual disabilities, or severe vision and hearing impairment [14][8].

Accessing Early Intervention

Do not wait for a delay to become obvious before seeking help. Ask your pediatrician for a referral for an evaluation with your local or state Early Intervention program right away. An evaluation will determine if your child qualifies for services based on their medical history (like a high-grade bleed) or any identified delays.

Early intervention programs take advantage of a young child’s brain plasticity—the ability of the brain to rewire and adapt after an injury. Participating in therapies early can significantly improve motor and cognitive outcomes at age two and beyond [15][16].

Common questions in this guide

How does the severity of my baby's intracranial hemorrhage affect their long-term health?
Outcomes depend heavily on the hemorrhage grade. Lower-grade bleeds often result in normal development with minor risks, while higher-grade bleeds increase the risk of cerebral palsy, intellectual disabilities, and vision or hearing impairments.
What signs of fluid buildup in the brain should I watch for after an ICH?
You should watch for rapid head growth, which your pediatrician will monitor by measuring your baby's head circumference regularly. This can be a sign of post-hemorrhagic ventricular dilatation (PHVD), a condition that may require surgical intervention.
When should I ask for an Early Intervention evaluation for my child?
You should request a referral for an Early Intervention evaluation right away, even before any developmental delays become obvious. Early therapies take advantage of your baby's brain plasticity and can significantly improve long-term cognitive and motor outcomes.
What specialists will my baby need to see after leaving the NICU?
Your child's long-term care team will typically include a pediatric neurologist to monitor brain structure, a developmental pediatrician to track cognitive and motor skills, and Early Intervention professionals like physical and occupational therapists.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the exact grade of my child's intracranial hemorrhage, and what specific risks are associated with that severity?
  2. 2.What specific physical signs of fluid buildup (PHVD) should I be monitoring for at home between appointments?
  3. 3.What is our timeline for follow-up brain imaging, and will we use an MRI or an ultrasound?
  4. 4.How can I get a referral for an evaluation with our local or state Early Intervention program?
  5. 5.When should we schedule our first formal neurodevelopmental evaluation with a specialist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Antenatal management of fetal and neonatal alloimmune thrombocytopenia: Integration of clinical history and maternal HLA-DRB3*01:01 genotyping in clinical decision-making.

    Tomac G, Zorana G, Radošević V, et al.

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2026; (65(3)):104432 doi:10.1016/j.transci.2026.104432.

    PMID: 42001569
  2. 2

    Predicting neurodevelopmental outcomes in extremely preterm neonates with low-grade germinal matrix-intraventricular hemorrhage using synthetic MRI.

    Zhang C, Zhu Z, Wang K, et al.

    Frontiers in neuroscience 2024; (18()):1386340 doi:10.3389/fnins.2024.1386340.

    PMID: 39170683
  3. 3

    Point of Care Neonatal Ultrasound - Head, Lung, Gut and Line Localization.

    Rath C, Suryawanshi P

    Indian pediatrics 2016; (53(10)):889-899.

    PMID: 27484449
  4. 4

    Post-hemorrhagic ventricular dilatation: inter-observer reliability of ventricular size measurements in extremely preterm infants.

    Leijser LM, Scott JN, Roychoudhury S, et al.

    Pediatric research 2021; (90(2)):403-410 doi:10.1038/s41390-020-01245-0.

    PMID: 33184496
  5. 5

    Neonatal follow-up programs in Canada: A national survey.

    Albaghli F, Church P, Ballantyne M, et al.

    Paediatrics & child health 2021; (26(1)):e46-e51 doi:10.1093/pch/pxz159.

    PMID: 33542778
  6. 6

    Impaired hippocampal development and outcomes in very preterm infants with perinatal brain injury.

    Strahle JM, Triplett RL, Alexopoulos D, et al.

    NeuroImage. Clinical 2019; (22()):101787 doi:10.1016/j.nicl.2019.101787.

    PMID: 30991622
  7. 7

    Increased frequency of autism by previous diagnosis and screening in children with fetal-neonatal alloimmune thrombocytopenia with and without an intracranial hemorrhage.

    McFarland EA, Knightly KA, Vander Haar E, et al.

    American journal of obstetrics and gynecology 2025; (233(6)):656.e1-656.e11 doi:10.1016/j.ajog.2025.06.052.

    PMID: 40582444
  8. 8

    Association of germinal matrix hemorrhage volume with neurodevelopment and hydrocephalus.

    Yang PH, Karuparti S, Varagur K, et al.

    Journal of neurosurgery. Pediatrics 2024; (34(4)):347-356 doi:10.3171/2024.3.PEDS22376.

    PMID: 38968622
  9. 9

    Children Newly Diagnosed with Fetal and Neonatal Alloimmune Thrombocytopenia: Neurodevelopmental Outcome at School Age.

    de Vos TW, van Zagten M, de Haas M, et al.

    The Journal of pediatrics 2023; (258()):113385 doi:10.1016/j.jpeds.2023.02.031.

    PMID: 36933767
  10. 10

    Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia.

    de Vos TW, de Haas M, Oepkes D, et al.

    American journal of obstetrics and gynecology 2022; (227(4)):637.e1-637.e9 doi:10.1016/j.ajog.2022.05.063.

    PMID: 35671780
  11. 11

    Decreased Cerebral Oxygenation in Premature Infants with Progressive Posthemorrhagic Ventricular Dilatation May Help with Timing of Intervention.

    June A, Heck T, Shah TA, et al.

    American journal of perinatology 2023; (40(13)):1446-1453 doi:10.1055/s-0041-1736533.

    PMID: 34674212
  12. 12

    Prediction of short- and long-term outcomes using pre-operative ventricular size in infants with post-hemorrhagic ventricular dilation.

    Serebin M, Zhang J, Yan K, et al.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2024; (40(7)):2061-2069 doi:10.1007/s00381-024-06371-2.

    PMID: 38532147
  13. 13

    Neurodevelopmental outcomes in preterm or low birth weight infants with germinal matrix-intraventricular hemorrhage: a meta-analysis.

    Zhou M, Wang S, Zhang T, et al.

    Pediatric research 2024; (95(3)):625-633 doi:10.1038/s41390-023-02877-8.

    PMID: 37935882
  14. 14

    Beyond the bleed: Navigating fetal intraventricular hemorrhage.

    Lee HC, Amin AA, Gonzales DN

    Journal of neonatal-perinatal medicine 2024; (17(6)):858-862 doi:10.1177/19345798241308494.

    PMID: 40016979
  15. 15

    Early versus Late Ventricular Intervention Study (ELVIS) in post-hemorrhagic ventricular dilatation: Bayesian reanalysis of brain injury and outcomes.

    Cizmeci MN, de Vries LS, Whitelaw A, et al.

    Pediatric research 2026; doi:10.1038/s41390-026-05172-4.

    PMID: 42265277
  16. 16

    Implementation of an early intervention strategy for post hemorrhagic ventricular dilatation in preterm infants.

    Wilson D, Breitbart S, DiFonzo L, et al.

    Journal of perinatology : official journal of the California Perinatal Association 2026; (46(6)):964-970 doi:10.1038/s41372-025-02371-5.

    PMID: 40715736

This page explains long-term monitoring for intracranial hemorrhage caused by FNAIT for educational purposes only. Always consult your child's pediatrician and neurologist for medical advice and individualized care plans.

Get notified when new evidence is published on Fetal and neonatal alloimmune thrombocytopenia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.